GlassScriptPhysician profile
Don J Nishiguchi
NPI 1043368277
$3,309.58
in general payments reported to CMS, 2019-2025
32 companies · $73.67 in 2025
The $73.67 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $393 · 2021: $732 · 2022: $681 · 2023: $762 · 2024: $166 · 2025: $73.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $976.26 | 2019-2023 | |
| Exeltis, USA INC. | $323.94 | 2020-2024 | Slynd, Solosec |
| Mayne Pharma Commercial LLC | $250.40 | 2022-2025 | |
| Allergan, INC. | $171.93 | 2019-2020 | |
| Avion Pharmaceuticals | $155.65 | 2019-2022 | |
| Therapeuticsmd, INC. | $142.01 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $135.98 | 2019-2020 | |
| Evofem Biosciences, INC. | $121.38 | 2020-2023 | Phexxi |
| Myovant Sciences INC. | $120.88 | 2022 | |
| Sumitomo Pharma America, INC. | $116.44 | 2023 | Myfembree |
| Pfizer INC. | $80.38 | 2023-2024 | |
| Organon LLC | $69.99 | 2022-2024 | |
| Agile Therapeutics, INC. | $65.36 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.42 | 2019-2020 | |
| Hologic Sales and Service, LLC | $59.00 | 2022-2023 | Acessa Provu System, Coolseal Generator |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $49.03 | 2019-2022 | |
| Astellas Pharma US INC | $47.08 | 2024 | Veozah |
| Daiichi Sankyo INC. | $42.05 | 2021 | |
| Ascend Therapeutics US, LLC | $39.38 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $36.40 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $35.61 | 2021 | |
| Lupin INC. | $26.07 | 2019 | |
| Medtronic, INC. | $25.00 | 2021 | |
| Exact Sciences Corporation | $24.72 | 2023 | Cologuard Collection Kit |
| Duchesnay USA Incorporated | $20.58 | 2019 | |
| Horizon Therapeutics Plc | $20.20 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.92 | 2022 | |
| Ethicon US, LLC | $17.95 | 2025 | Harmonic |
| Mission Pharmacal Company | $17.23 | 2021 | |
| Shield Therapeutics INC | $15.47 | 2024 | |
| Channel Medsystems, INC. | $13.64 | 2022 | |
| Zyla Life Sciences, INC. | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Nishiguchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.